Skip to main content
SpringerLink
Log in

Pheochromocytoma Treatment

  • Chapter
Secondary Hypertension

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

Abstract

Surgical resection remains the cornerstone of pheochromocytoma therapy. Because most of these tumors are benign and unifocal, resection produces a permanent cure. Prior to 1950, the operative mortality was more than 25% . With a better understanding of the potential complications that contribute to perisurgical mortality and with the introduction of α-adrenergic antagonists, the current surgical mortality is 2% or less. Surgical therapies continue to evolve and are supported by a greater choice of localizing techniques and treatment strategies both preoperatively and perioperatively. Combined surgical and medical therapy is required for the management of metastatic pheochromocytoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Duh Q-Y. Evolving surgical management for patients with pheochromocytoma. J Clin Endocrinol Metab 2001: 86: 1477–1479.

    Article  PubMed  CAS  Google Scholar 

  2. Kvale W, Roth G, Manger W, Priestley T. Pheochromocytoma. Circulation 1956:14;622–630.

    Article  PubMed  CAS  Google Scholar 

  3. Plouin P-F, Duclos J-M, Soppelsa F, Boublil G, Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab 2001:86;1480–1486.

    Article  PubMed  CAS  Google Scholar 

  4. Boutros A, Bravo E, Zanettin G, Straffon R. Perioperative management of 63 patients with pheochromocytoma. Cleve Clin J Med 1990:57;613–617.

    PubMed  CAS  Google Scholar 

  5. Ulchaer J, Goldfarb D, Bravo E, Novick A. Successful outcomes of phcochromocytoma surgery in the modern era. J Urol 1999:61;764–767.

    Google Scholar 

  6. Knapp H, Fitzgerald G. Hypertensive crisis in prazosin-treated pheochromocytoma. S Med J 1984:77;535–536.

    Article  CAS  Google Scholar 

  7. Havkujm R, Cahow C, Kindre B. Advances in the diagnosis and treatment of pheochromocytoma. Arch Surg 1988:123;626–630.

    Article  Google Scholar 

  8. Ram C, Meese R, Hill S. Failure of alpha-methyltyrosine to prevent hypertensive crisis in pheochromocytoma. Arch Intern Med 1985:145;2114–2115.

    Article  PubMed  CAS  Google Scholar 

  9. Steinsapir J, Can A, Prisant L, Bransome E. Metyrosine and pheochromocytoma. Arch Intern Med 1997:157;901–906.

    Article  PubMed  CAS  Google Scholar 

  10. Perry R, Keiser H, Norton J, et al. Surgical management of pheochromocytoma with the use of metyrosine. Ann Surg 1990:212;621–628.

    Article  PubMed  CAS  Google Scholar 

  11. Pogson G, Sharma J, Crouch T. Pulmonary edema with low-dose propranolol in pheochromocytoma. S Med J 1980:73;795–796.

    Article  CAS  Google Scholar 

  12. Wark J, Larkins R. Pulmonary oedema after propranolol therapy in two cases of phaeochromocytoma. BMJ 1978:1;1395–1396.

    Article  PubMed  CAS  Google Scholar 

  13. Pearce CJ, Wallin JD. Labetalol and other agents that block both alpha- and betaadrenergic receptors. Cleve Clin J Med 1994:61;59–69.

    PubMed  CAS  Google Scholar 

  14. Kanto J. Current status of labetalol, the first alpha- and beta-blocking agent. Int J Clin Pharmacol Ther Toxicol 1985:23;617–628.

    PubMed  CAS  Google Scholar 

  15. Briggs R, Birtwell A, Pohl J. Hypertensive response to labetalol in phaeochromocytoma. Lancet 1978:13;1045–1046.

    Article  Google Scholar 

  16. Crawford GA, Gyory AZ, Gallery ED, Kelley D. HPLC of urinary catecholamines in the presence of labetalol, captopril, and alpha-methyldopa. J Clin Chem 1990:36;1849.

    CAS  Google Scholar 

  17. Khafagi FA, Shapiro B, Fig LM, Mallette S, Sisson JC. Labetalol reduces iodine131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med 1989:30;481–489.

    PubMed  CAS  Google Scholar 

  18. Brunjes S, Johns V, Crane M. Pheochromocytoma: postoperative shock. N Engl J Med 1960:262;393–396.

    Article  PubMed  CAS  Google Scholar 

  19. Spark R, Connolly P, Gluckin D, White R, Sacks B, Landsberg L. ACTH secretion from a functioning pheochromocytoma. N Engl J Med 1979:23;416–418.

    Article  Google Scholar 

  20. Proye C, Huart J, Cuvillier X, Assez M, Gambardella B, Carnaille B. Safety of the posterior approach in adrenal surgery. Surgery 1993:114;1126–1131.

    PubMed  CAS  Google Scholar 

  21. Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. N Engl J Med 1992:327;1033.

    Article  PubMed  CAS  Google Scholar 

  22. Brunt L, Moley J, Doherty G, Lairmore T, Debenedetti M, Quasebarth M. Outcome analysis in patients undergoing laparoscopic adrenalectomy for hormonally active adrenal tumors. Surgery 2001:130;629–635.

    Article  PubMed  CAS  Google Scholar 

  23. Col V, Canniere L, Collard E, Michel L, Donckier J. Laparoscopic adrenalectomy for phaeochromocytoma: endocrinological and surgical aspects of a new therapeutic approach. Clin Endocrinol 1999:50;121–125.

    Article  CAS  Google Scholar 

  24. Janetschek G, Neumann H. Laparoscopic surgery for pheochromocytoma. Urol Clin N Am 2001:28;97–105.

    Article  CAS  Google Scholar 

  25. Shichman S, Herndon C, Sosa R, et al. Lateral transperitoneal laparoscopic adrenalectomy. World J Urol 1999:17;48–53.

    Article  PubMed  CAS  Google Scholar 

  26. Salomon L, Rabii R, Soulie M, et al. Experience with retroperitoneal laparoscopic adrenalectomy for pheochromocytoma. J Urol 2001:165;1871–1874.

    Article  PubMed  CAS  Google Scholar 

  27. Gagner M, Breton G, Pharand D, Pomp A. Is laparoscopic adrenalectomy indicated for pheochromocytomas? Surgery 1996:120;1076–1080.

    Article  PubMed  CAS  Google Scholar 

  28. Li M. Fitzgerald P, Price D, Norton J. Iatrogenic pheochromocytomatosis: a previously unreported result of pheochromocytoma. Surgery 2001;1072–1077.

    Google Scholar 

  29. MacGillivray D, Whalen GF, Malchoff CD, Oppenheim DS, Shichman SJ. Laparoscopic resection of large adrenal tumors. Ann Surg Oncol 2002;130: 480–485.

    Article  Google Scholar 

  30. Averbuch S, Steakley C, Young R, et al. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Int Med 1988:102;267–273.

    Google Scholar 

  31. Pacak K, Fojok T, Goldstein D, et al. Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma. J Natl Cancer Institute 2001:2001; 648–649.

    Google Scholar 

  32. Adams S, Acker P, Lorenz M, Staib-Sebler E, Hor G. Radioisotope-guided surgery in patients with pheochromocytoma and intraoperative tumor localization with histopathologic findings. Cancer 2001:92;263–270.

    Article  PubMed  CAS  Google Scholar 

  33. Keiser HR, Goldstein DS, Wade JL, Douglas FL, Averbuch SD. Treatment of malignant pheochromocytoma with combination chemotherapy. Hypertension 1985:7(Suppl I);18–24.

    Article  Google Scholar 

  34. Loh K, Fitzgerald P, Matthay K, Yeo P, Price D. The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 1997:11;648–658.

    Google Scholar 

  35. Sisson J, Shapiro B, Beierwaltes W, et al. Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med 1984:24;197–206.

    Google Scholar 

  36. Sisson JC, Shapiro B, Shulkin BL, Urba S, Zempel S, Spaulding S. Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy. Am J Clin Oncol 1999:22;364–370.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Carl D. Malchoff MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dougald MacGillivray MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven Shichman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Section of Hypertension and Clinical Pharmacology, University of Connecticut School of Medicine, Farmington, CT, USA

    George A. Mansoor MD, FRCP (EDIN)

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Malchoff, C.D., MacGillivray, D., Shichman, S. (2004). Pheochromocytoma Treatment. In: Mansoor, G.A. (eds) Secondary Hypertension. Clinical Hypertension and Vascular Diseases. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-757-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-757-4_14

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-383-1

  • Online ISBN: 978-1-59259-757-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation